Genovate Biotechnology Co Ltd (4130) — Cash Flow Reinvestment Rate
Genovate Biotechnology Co Ltd (4130) has a Cash Flow Reinvestment Rate of 0.63x as of December 2025, reinvesting NT$10.75 Million (capex NT$8.19 Million plus investments NT$-2.56 Million) from operating cash flow of NT$16.93 Million. Explore Genovate Biotechnology Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genovate Biotechnology Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Genovate Biotechnology Co Ltd across 10 annual periods. Also explore 4130 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Genovate Biotechnology Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Genovate Biotechnology Co Ltd. For live market cap and broader valuation context, see market value of Genovate Biotechnology Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.91x | NT$83.63 Million | NT$43.79 Million | NT$61.42 Million | ▲ +21.1% |
| 2024 | 1.58x | NT$86.92 Million | NT$55.11 Million | NT$31.37 Million | ▲ +79.5% |
| 2023 | 0.88x | NT$74.49 Million | NT$84.78 Million | NT$33.34 Million | ▼ -95.5% |
| 2022 | 19.71x | NT$29.76 Million | NT$1.51 Million | NT$24.01 Million | ▲ +4606.1% |
| 2020 | 0.42x | NT$36.47 Million | NT$87.08 Million | NT$27.01 Million | ▼ -69.9% |
| 2019 | 1.39x | NT$61.76 Million | NT$44.43 Million | NT$25.76 Million | ▲ +84.0% |
| 2018 | 0.76x | NT$47.49 Million | NT$62.88 Million | NT$35.26 Million | ▼ -93.9% |
| 2017 | 12.33x | NT$385.65 Million | NT$31.27 Million | NT$38.53 Million | ▲ +1345.3% |
| 2016 | 0.85x | NT$60.22 Million | NT$70.58 Million | NT$40.87 Million | ▼ -91.8% |
| 2015 | 10.42x | NT$338.87 Million | NT$32.53 Million | NT$53.75 Million | — |